New Jersey Better Educational Savings Trust Lowered Cui Global (CUI) Stake By $360,000; Alliqua (ALQA) Has 2.33 Sentiment

July 18, 2017 - By Darrin Black

New Jersey Better Educational Savings Trust decreased Cui Global Inc (CUI) stake by 54.55% reported in 2016Q4 SEC filing. New Jersey Better Educational Savings Trust sold 60,000 shares as Cui Global Inc (CUI)’s stock declined 38.03%. The New Jersey Better Educational Savings Trust holds 50,000 shares with $347,000 value, down from 110,000 last quarter. Cui Global Inc now has $77.77 million valuation. The stock decreased 1.33% or $0.05 on July 17, reaching $3.7. About shares traded. CUI Global Inc (NASDAQ:CUI) has declined 32.86% since July 18, 2016 and is downtrending. It has underperformed by 49.56% the S&P500.

Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The company has market cap of $17.72 million. The Company’s businesses include advanced wound care and contract manufacturing. It currently has negative earnings. The Firm operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc.

Analysts await CUI Global Inc (NASDAQ:CUI) to report earnings on August, 14. They expect $-0.10 EPS, down 100.00% or $0.05 from last year’s $-0.05 per share. After $-0.17 actual EPS reported by CUI Global Inc for the previous quarter, Wall Street now forecasts -41.18% EPS growth.

New Jersey Better Educational Savings Trust increased Facebook Inc (NASDAQ:FB) stake by 7,000 shares to 41,000 valued at $4.72M in 2016Q4. It also upped Microsoft Corp (NASDAQ:MSFT) stake by 11,000 shares and now owns 67,000 shares. Visa Inc (NYSE:V) was raised too.

Since May 12, 2017, it had 9 insider purchases, and 0 selling transactions for $137,117 activity. $4,823 worth of CUI Global Inc (NASDAQ:CUI) shares were bought by White Paul Dwayne. Another trade for 5,000 shares valued at $16,590 was bought by FORD DANIEL NED. CLOUGH WILLIAM J bought 17,500 shares worth $57,320. The insider MCKENZIE MATTHEW MURDOCK bought 1,040 shares worth $3,921.

Among 3 analysts covering CUI Global (NASDAQ:CUI), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CUI Global had 4 analyst reports since December 23, 2015 according to SRatingsIntel. Dougherty & Company maintained CUI Global Inc (NASDAQ:CUI) on Wednesday, May 11 with “Buy” rating. Dougherty & Company maintained CUI Global Inc (NASDAQ:CUI) rating on Friday, November 11. Dougherty & Company has “Buy” rating and $7.0 target. The stock has “Buy” rating by Rodman & Renshaw on Wednesday, December 23.

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.24, from 1.44 in 2016Q3. It is negative, as 4 investors sold CUI shares while 11 reduced holdings. 5 funds opened positions while 13 raised stakes. 11.83 million shares or 2.29% less from 12.11 million shares in 2016Q3 were reported. Brown Advisory Inc has 12,475 shares. New Jersey Better Educational Savings Trust reported 50,000 shares. Blackrock Institutional Trust Company Na, California-based fund reported 24,486 shares. Blackrock Investment Mgmt Lc reported 3,541 shares. Clear Harbor Asset Management Ltd Liability Co, New York-based fund reported 1.15 million shares. Wells Fargo Company Mn has invested 0% in CUI Global Inc (NASDAQ:CUI). First Wilshire Mngmt invested in 1.28% or 647,475 shares. Creative Planning has 300 shares. 2.40 million are held by First Eagle Invest Management Limited. Raymond James And Assocs has invested 0% in CUI Global Inc (NASDAQ:CUI). Eidelman Virant Capital has 37,127 shares for 0.15% of their portfolio. 20,751 are held by Morgan Stanley. Heartland reported 2.26M shares or 0.87% of all its holdings. Bessemer Grp has 0% invested in CUI Global Inc (NASDAQ:CUI) for 16,000 shares. 19,933 were accumulated by Bancorp Of New York Mellon Corp.

The stock decreased 5.13% or $0.02 on July 17, reaching $0.37. About shares traded. Alliqua Biomedical Inc (ALQA) has declined 66.38% since July 18, 2016 and is downtrending. It has underperformed by 83.08% the S&P500.

Pura Vida Investments Llc holds 0.13% of its portfolio in Alliqua Biomedical Inc for 583,026 shares. Suffolk Capital Management Llc owns 1.17 million shares or 0.09% of their US portfolio. Moreover, Perceptive Advisors Llc has 0.08% invested in the company for 1.92 million shares. The New Jersey-based Sabby Management Llc has invested 0.04% in the stock. Tekla Capital Management Llc, a Massachusetts-based fund reported 1.65 million shares.

Analysts await Alliqua Biomedical Inc (NASDAQ:ALQA) to report earnings on August, 8. They expect $-0.14 EPS, up 41.67% or $0.10 from last year’s $-0.24 per share. After $-0.19 actual EPS reported by Alliqua Biomedical Inc for the previous quarter, Wall Street now forecasts -26.32% EPS growth.